About Medicinal Genomics
Medicinal Genomics is a Healthcare company based in Woburn (United States) founded in 2011, and was acquired by Courtagen in January 2012. It operates as a provider of cannabis sequencing services. It operates in the Healthcare and Agriculture sectors. Medicinal Genomics has raised $7.69 million across 2 funding rounds from investors including Courtagen. Medicinal Genomics offers products and services including PathoSEEK® qPCR Detection Assays, MaGiC Lysis Kits, FemINDICAtor® qPCR Plant Gender Detection Assay, and SenSATIVAx® DNA Purification Kits. Its focus areas include Life Sciences, Genomics, Applied Genomics and Agrigenomics. Its legal entity is Medicinal Genomics Corps. Its competitors include Benson Hill, Cibus, Pairwise, Inari and Ceres and 3 more; 7 of its 8 listed competitors have raised funding.
Company details
Medicinal Genomics was founded in 2011 and is based in Woburn, United States. Cannabis sequencing services are offered, including a DNA database for the plant. Fingerprinting assays are planned, encompassing DNA purification, gender testing, and microbial testing. These support strain genotyping and sequencing for development in the genomics sector.
- Headquarters Woburn, United States
- Stage Acquired
- SectorsHealthcareAgriculture
- Website category Health · Addictions
- Email••••••••
- Phone•••• ••••
- Website medicinalgenomics.com
- Social LinkedIn X Facebook Instagram YouTube
- Acquired by Courtagen (Jan 2012)
- Legal Name Medicinal Genomics Corps
Products & Services of Medicinal Genomics
Medicinal Genomics offers a comprehensive portfolio of products and services, including PathoSEEK® qPCR Detection Assays, MaGiC Lysis Kits, FemINDICAtor® qPCR Plant Gender Detection Assay, and SenSATIVAx® DNA Purification Kits.
Detects pathogens in cannabis plants using qPCR technology.
Prepares samples for genomic analysis in plant testing.
Identifies plant gender early to optimize breeding processes.
Purifies DNA for accurate microbial and genetic testing.
Apps and channels of Medicinal Genomics
its YouTube channel Medicinal has 52K subscribers and 30 videos.
Videos from Medicinal Genomics
The most watched videos on Medicinal Genomics's YouTube channel, Medicinal (52K subscribers). Click a video to play it here.
More on Medicinal.
Funding Insights of Medicinal Genomics
Medicinal Genomics has successfully raised a total of $7.69M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $2.68 million completed in April 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $7.69M
- Total Rounds 2
- Last Round Series A — $2.68M
- First Round $5M
(Nov 2017)
All 2 funding rounds of Medicinal Genomics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2021 | $2.68M | Series A | – | – | – |
| Nov 2017 | $5M | Series A | – | – | – |
1 investors in total: 1 institutional.
Investors in Medicinal Genomics
Medicinal Genomics has secured backing from 1 investor. Prominent investors backing the company include Courtagen.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Provides solutions for neurological and metabolic disorders. | 2009 | courtagen.com | Woburn, United States |
Investor details for Medicinal Genomics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Medicinal Genomics
9 people are tracked at Medicinal Genomics (5 in leadership, 4 in team).
| Name | Role | Group |
|---|---|---|
Sam Hindmarsh | Director Of Business Development, CannMed Events | Leadership |
Timothy Olcott | Senior Vice President Operations | Leadership |
Brendan M. | Chief Executive Officer & Board Member | Leadership |
Douglas K. | CannMed Events Managing Director and Co-Founder | Leadership |
Daniel Walsh | Vice President of Sales | Leadership |
David Rapisarda | Operations Manager | Team |
Nick Tassinari | Inside Sales & Customer Support Representative | Team |
Zac Eaton | Senior Sales Representative | Team |
Arlene Barbieri | Corporate Financial Controller | Team |
Complete people profiles for Medicinal Genomics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Medicinal Genomics
4 dated milestones of Medicinal Genomics across 10 years, from founding to its latest funding, stage changes and deals.
- Founded Medicinal Genomics is founded.
- Exit Acquired by Courtagen.
- Funding First funding round of $5.0M.
- Funding Latest funding round, Series A, of $2.7M.
Competitors of Medicinal Genomics
Medicinal Genomics has 8 listed competitors in our database, 7 of them funded. They include Benson Hill, Cibus, Pairwise, Inari and Ceres, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| bensonhill.com | 2012 | St. Louis, United States | $406.99M | 151 | Provider of plant-based food ingredients | |
| cibus.com | 2001 | San Diego, United States | $34.47M | 129 | Gene editing solutions are provided for agriculture. | |
| pairwise.com | 2017 | Durham, United States | $155M | – | New crop varieties are developed using gene-editing for agrigenomics. | |
| inari.com | 2016 | Cambridge, United States | $708M | 143 | Breeding technology is provided by Inari to design seeds. | |
| ceres.com | 1996 | Milan, Italy | – | – | Beers are produced and branded by Ceres in Italy. | |
| hifidelitygenetics.com | 2014 | Durham, United States | $8.5M | 1 | Developer of a predictive breeding platform to identify crop traits and build crop models | |
| chromatininc.com | 2000 | Chicago, United States | $121.7M | 92 | Sorghum seeds are produced for biofuels, feed, and food uses. | |
| phylos.bio | 2014 | Portland, United States | $28.41M | 61 | Developer of cannabis breeding tools for agriculture & other health purposes |
Detailed competitors of Medicinal Genomics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Medicinal Genomics
The website of Medicinal Genomics (medicinalgenomics.com) receives about 9.4K visits a month and ranks #1,651,106 among all websites worldwide, #1,942 in Addictions.
- Monthly visits9.4K
▲ 10.8% vs previous month
- Unique visitors3.3K
per month
- Global rank#1,651,106
among all websites
- Category rank#1,942
Health · Addictions
- Bounce rate41%
- Pages per visit5.8
- Average visit3 min 26 sec
- DevicesDesktop 46% · Mobile 54%
Websites whose visitors overlap most with Medicinal Genomics. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
420-seeds.com | 420-seeds.com | 100% | – | #461,848 | – |
 medicalcbd.wordpress.com | medicalcbd.wordpress.com | 91% | – | – | – |
cannabisplus.net | cannabisplus.net | 90% | – | – | – |
ilgmforum.com | ilgmforum.com | 85% | – | #353,253 | – |
| growweedeasy.com | 85% | – | #169,021 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 11 similar websites and full traffic analytics for Medicinal Genomics
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 11 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
10 companies that operate in the same segment as Medicinal Genomics (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.34 B | USD 301.49 M | 1,372 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 562 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Medicinal Genomics
Complete news archive for Medicinal Genomics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Medicinal Genomics
Medicinal Genomics was founded in 2011 and raised its 1st funding round 6 years after it was founded.
Medicinal Genomics is headquartered in Woburn, United States. It is registered at Woburn, Massachusetts, United States.
Medicinal Genomics is a funded company, having raised a total of $7.69M across 2 funding rounds to date. The company's 1st funding round was a Series A of $5M, raised on Nov 2017.
Medicinal Genomics was founded in 2011 and is based in Woburn, United States. Cannabis sequencing services are offered, including a DNA database for the plant. Fingerprinting assays are planned, encompassing DNA purification, gender testing, and microbial testing. These support strain genotyping and sequencing for development in the genomics sector.
Medicinal Genomics's top competitors include Benson Hill, Cibus and Inari.
Medicinal Genomics offers PathoSEEK® qPCR Detection Assays, MaGiC Lysis Kits, FemINDICAtor® qPCR Plant Gender Detection Assay, and SenSATIVAx® DNA Purification Kits.
Medicinal Genomics has 1 investor. Key investors include Courtagen.
Medicinal Genomics operates through Medicinal Genomics Corps.
Yes. Medicinal Genomics was acquired by Courtagen in January 2012.